Healthcare Revenue Cycle Management, ICD-10, Claims Reimbursement, Medicare, Medicaid

Prescription Drug Rates

Prescription Drug Rate Growth Slows, But Prices Still Rising 7.35%

February 1, 2018 - Providers should anticipate a 7.35 percent increase in prescription drug rates between July 2018 and June 2019, researchers from Vizient projected in a new study. Based on hospital and non-acute facility purchasing data from the company’s Pharmacy Program, Vizient described the projected price increases as a “slightly moderated level of growth.” Last year, providers faced...


More Articles

85% of Hospitals to See Part B Increase Despite 340B Payment Cuts

by Jacqueline Belliveau

EDITOR'S NOTE: This article has been updated with a statement from the American Hospital Association. Approximately 85 percent of hospitals will receive a net increase in their total Medicare Part B reimbursements despite recent Outpatient...

Health Systems Form Drug Company to Combat Rising Costs, Shortages

by Jacqueline Belliveau

Intermountain Healthcare, Ascension, SSM Health, and Trinity Health recently announced that they will create a non-profit generic drug company to reduce prescription costs and alleviate critical drug shortages. With consulting services with the...

Prescription Drug Rates Continue to Challenge Cancer Centers

by Jacqueline Belliveau

Prescription drug rates and the costs of new treatment modalities continued to challenge cancer centers, according to the most recent Trending Now in Cancer Care survey from the Association of Community Cancer Centers (ACCC). For the second year...

Judge Denies Hospital Org Attempt to Block 340B Drug Payment Cut

by Jacqueline Belliveau

A federal judge recently ruled that CMS can start to reduce 340B drug payments to hospitals by $1.6 billion starting on Jan. 1, 2018, striking a blow to several industry groups that urged the court to delay enforcement of the new rule. US District...

Orgs Argue MIPS Adjustments for Drug Payments Harm Patient Access

by Jacqueline Belliveau

Applying Merit-Based Incentive Payment System (MIPS) adjustments to Medicare Part B drug payments will restrict patient access to critical treatments, 11 medical societies recently told congressional leaders. The medical societies, including...

House Reps Aim to Stop $1.6B Hospital Payment Cut for 340B Drugs

by Jacqueline Belliveau

A new bipartisan bill intends to block CMS from enforcing a $1.6 billion Medicare reimbursement cut under the 340B Drug Pricing Program. Representatives David McKinley (R-WV) and Mike Thompson (D-CA) introduced H.R. 4392 last week. The bill would...

Providers Who Accept Pharma Gifts Prescribe More Expensive Drugs

by Jacqueline Belliveau

Providers in the DC area who received gifts from the pharmaceutical industry tended to prescribe more drugs per patient, including more expensive, branded medications, than their peers who did not accept gifts, a recent PLoS One study showed....

Hospital Orgs to Sue CMS Over 340B Medicare Reimbursement Cuts

by Jacqueline Belliveau

The American Hospital Association (AHA), America’s Essential Hospitals, and the Association of American Medical Colleges (AAMC) recently announced their intentions to pursue litigation against CMS to prevent Medicare reimbursement reductions...

Over 1,300 Hospitals Urge CMS to Withdraw 340B Drug Payment Cuts

by Jacqueline Belliveau

Over 1,300 rural hospitals and other healthcare organizations that serve low-income communities added their voices to the growing list of stakeholders opposing proposed payment cuts to the 340B Drug Pricing program. CMS proposed in July 2017...

Advisory Group Warns CMS Against 340B Medicare Reimbursement Cuts

by Jacqueline Belliveau

The CMS Advisory Panel on Hospital Outpatient Payment recently called on the federal agency to abandon proposed changes to the 340B Drug Pricing Program in 2018, which would reduce Medicare reimbursement to qualifying hospitals for drugs acquired...

Hospitals to See 7.61% Rise in 2018 Prescription Drug Rates

by Jacqueline Belliveau

Hospitals and health systems should anticipate a 7.61 percent increase in prescription drug rates in 2018, researchers predicted in a recent Vizient study. Using the group purchasing organization’s 2016 and 2017 data on hospital and non-acute...

Hospital Orgs Oppose Site-Neutral Medicare Reimbursement Cuts

by Jacqueline Belliveau

Several hospital groups recently spoke out against proposed 2018 Medicare reimbursement updates that would reduce site-neutral payments to off-campus provider-based departments from 50 percent of the outpatient rate to 25 percent. CMS recently...

Hospitals, ASCs, 340B Drugs Face Medicare Reimbursement Changes

by Jacqueline Belliveau

CMS recently proposed a rule that would update Medicare reimbursement rates for hospitals and ambulatory surgical centers as well as change some prescription drug rates to 340B hospitals. Hospitals would see a 2 percent Medicare reimbursement...

Provider Profitability Drops Under Biosimilar Use Reimbursement

by Jacqueline Belliveau

Biosimilar use could be the key to lowering healthcare costs associated with biologic treatments, but provider profitability may suffer by as much as $100 million across care settings if providers continue to administer the low-cost alternative,...

96% of Healthcare Execs Report Rise in Inpatient Drug Spending

by Jacqueline Belliveau

Approximately 64 percent of healthcare executives reported that inpatient drug spending at their organization significantly increased over the past five years, a recent Premier Inc survey revealed. Another 32 percent said that it somewhat...

Will Behavioral Economics Improve Alternative Payment Models?

by Jacqueline Belliveau

Alternative payment models may need to account for the behavioral economics behind provider prescribing habits to effectively reduce healthcare costs from expensive medications and treatments, a recent American Journal of Managed Care study stated....

Prescription Drug Rates Remain Top Healthcare Supply Chain Issue

by Jacqueline Belliveau

Almost all health system executives (99 percent) in a recent Premier survey agreed that rising prescription drug rates continue to plague their healthcare supply chain. The winter 2017 survey of 91 C-suite executives at health systems also uncovered...

Medicare Spending on Drug Coverage Tripled from 2010 to 2015

by Jacqueline Belliveau

Medicare spending on prescription drugs under the Part D catastrophic coverage program more than tripled from 2010 to 2015, increasing from $10.8 billion to $33.2 billion, the Office of the Inspector General (OIG) recently reported. The significant...

Drug Costs, Limited Claims Reimbursement Challenge Cancer Care

by Jacqueline Belliveau

Cancer care centers named high prescription drug costs and lack of claims reimbursement for supportive services as the top challenges associated with providing care in 2016, according to an annual Association of Cancer Care Centers (ACCC) survey....

X

Join 30,000 of your peers and get free access to all webcasts and exclusive content

Sign up for our free newsletter:

Our privacy policy

no, thanks

Continue to site...